Kenvue Shares Plunge Amid Speculation of RFK Jr. Linking Tylenol to Autism
Kenvue Shares Plunge Amid Speculation of RFK Jr. Linking Tylenol to Autism Kenvue Inc. saw a sharp decline in its share price following a Wall Street Journal report indicating that Health and Human Services Secretary Robert F. Kennedy Jr. is likely to connect the company’s Tylenol painkiller to autism. While the agency has labeled the report as “speculation,” the news has already impacted investor confidence. The federal government is anticipated to release its comprehensive findings on autism later this month….